Biorestorative Therapies Inc (BRTX)

Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.21%0.02	0.02	0.01	0.30	0.03
Cost Of Revenue	351.41%0.01	0.00	0.01	0.01	0.00
Gross Profit	12.13%0.02	0.02	0.00	0.29	0.02
	11.49%3.40	3.84	3.71	3.60	4.83
Research and Development	26.68%1.93	2.63	2.59	2.23	1.71
Depreciation and Amortization	0.84%0.05	0.05	0.05	0.05	0.05
Operating Income/Loss	11.49%-3.39	-3.83	-3.71	-3.31	-4.81
	99.35%1.23	0.62	0.67	0.65	-0.53
Interest And Devidend Income	82.52%0.01	0.03	0.06	0.07	0.10
	32.84%-2.15	-3.21	-3.04	-2.66	-5.34
Attributable To Parent	32.84%-2.15	-3.21	-3.04	-2.66	-5.34
Basic Average Shares	17.73	-	9.12	8.74	8.36
Diluted Average Shares	17.73	-	9.12	8.74	8.36
Basic Earnings Per Share	-0.12	-	-0.33	-0.30	-0.64
Diluted Earnings Per Share	-0.12	-	-0.33	-0.30	-0.64